INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Most active filers · 30d

  1. 01Kurtz George0B / 220S220 trades$52.89M
  2. 02SPSaba Capital Management, L.P.66B / 18S · 11 late84 trades$24.31M
  3. 03SJSheena Jonathan0B / 57S57 trades$3.61M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SLSpeiser Michael L0B / 35S35 trades$14.00M
  8. 08RARothblatt Martine A0B / 33S33 trades$5.50M
  9. 09RJRubinstein Julie0B / 32S32 trades$5.48M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

69,655 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
13
GC
Glessner ColeenEVP, Quality & Ethics, and CPL
EBSEmergent BioSolutions Inc.
Grant or award
A—
44.8K sh
Mar 3, 2026Mar 5, 2026
Page 1170 of 1742
← PrevNext →
traded Mar 3, 2026
+2d
SEC Form 4

Evidence

13
RR
Ribeiro RamiroChief Medical Officer
EYPTEyePoint, Inc.
Open-market sale · 10b5-1 plan
SELL$44K
2,438 sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC Form 4

Evidence

13
VR
Vakacherla RaviCDIO of Provident Bank
PFSPROVIDENT FINANCIAL SERVICES INC
Tax withholding
F$22K
1,020 sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

13
VR
Vakacherla RaviCDIO of Provident Bank
PFSPROVIDENT FINANCIAL SERVICES INC
Tax withholding
F$18K
849 sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

13
SD
Silva Effie DSVP, General Counsel & Secy
FDPDEL MONTE CORP
Option exercise
M—
152 sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

12
KK
Kalia KumudChief Information Officer
GHGuardant Health, Inc.
Option exercise
M$100K
2,119 sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC Form 4

Evidence

12
BM
Bick Karen M.SVP - Chief People Officer
RALRalliant Corp
Open-market sale · 10b5-1 plan
SELL$247K
5,485 sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

12
KK
Kalia KumudChief Information Officer
GHGuardant Health, Inc.
Option exercise
M$164K
5,000 sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC Form 4

Evidence

12
WK
Williams Robert KirkChief People & Admin Officer
DFINDonnelley Financial Solutions, Inc.
Tax withholding
F$122K
2,352 sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

12
GA
Girdwood AmyChief People & Culture Officer
WBDWarner Bros. Discovery, Inc.
Tax withholding
F$197K
6,971 sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

12
VS
Venkataratnam SreelaChief Accounting Officer
RIVNRivian Automotive, Inc. / DE
Tax withholding
F$53K
3,535 sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC Form 4

Evidence

12
MG
McArdle GraceEVP, MANUFACTURING AND QUALITY
ELANElanco Animal Health Inc
Tax withholding
F$108K
4,322 sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

12
WC
Werner Edward CooperChief Financial Officer
FFIVF5, INC.
Open-market sale · 10b5-1 plan
SELL$157K
560 sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC Form 4

Evidence

11
BM
Brosius MarkSVP & Chief Mfg and Supply Cha
ISRGINTUITIVE SURGICAL INC
Open-market sale · 10b5-1 plan
SELL$316K
648 sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

11
BM
Brosius MarkSVP & Chief Mfg and Supply Cha
ISRGINTUITIVE SURGICAL INC
Open-market sale · 10b5-1 plan
SELL$321K
648 sh
Mar 5, 2026Mar 5, 2026
traded Mar 5, 2026
+0dSEC Form 4

Evidence

10
MP
McNamara PeterChief Scientific Officer
TECXTectonic Therapeutic, Inc.
Open-market sale · 10b5-1 plan
SELL$36K
1,649 sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

9
OT
Osben TeoChief Accounting Officer
RALRalliant Corp
Tax withholding
F$15K
329 sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC Form 4

Evidence

9
BL
Brown Claude LeonardChief Business Officer
PINSPINTEREST, INC.
Grant or award
A—
56.3K sh
Mar 5, 2026Mar 5, 2026
traded Mar 5, 2026
+0dSEC Form 4

Evidence

9
JS
Jacobson SamanthaDirector, Chief Strategy Officer
TTDTrade Desk, Inc.
Grant or award
A—
309.6K sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

9
FL
Freemen-Bosworth LaurenEVP/Gen Counsel & Corp Sec
PBIPITNEY BOWES INC /DE/
Grant or award
A—
19.7K sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

9
CD
Cassidy Charles DGeneral Counsel and Secretary
CMRCCommerce.com, Inc.
Tax withholding
F$7,628
2,577 sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

9
BC
Brackmann ChristophChief Financial Officer
NVCRNovoCure Ltd
Grant or award
A—
80.7K sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

9
SD
Silva Effie DSVP, General Counsel & Secy
FDPDEL MONTE CORP
Option exercise
M—
2,109 sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

9
PM
Paravasthu MukundChief Operating Officer
NVCRNovoCure Ltd
Grant or award
A—
7,518 sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

9
AD
Anderson Woodrow DChief Accounting Officer
INDVIndivior Pharmaceuticals, Inc.
Option exercise
M—
24.0K sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

9
WL
Wu LeiDirector, Chief Executive Officer, 10% Owner
GCTGigaCloud Technology Inc
Open-market sale · 10b5-1 plan
SELL$351K
8,283 sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

9
OT
Osben TeoChief Accounting Officer
RALRalliant Corp
Tax withholding
F$32K
700 sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

9
AA
Aragone AugustoExecutive VP, Secretary & GC
INGMIngram Micro Holding Corp
Tax withholding
F$30K
1,424 sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

9
BS
Ban Hubert SChief Accounting Officer
CMRCCommerce.com, Inc.
Tax withholding
F$7,521
2,541 sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

9
BB
Ben Arye BarakGeneral Counsel
NVCRNovoCure Ltd
Grant or award
A—
73.3K sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

9
WL
Wu LeiDirector, Chief Executive Officer, 10% Owner
GCTGigaCloud Technology Inc
Open-market sale · 10b5-1 plan
SELL$660K
15.9K sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

9
PR
Preblick RyanChief Financial Officer
INDVIndivior Pharmaceuticals, Inc.
Option exercise
M—
113.5K sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

9
SS
Sanfrey Jeffrey ScottChief Operating Officer
BLBDBlue Bird Corp
Option exercise
M—
5,192 sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC Form 4

Evidence

9
LD
Lentz DanielCFO & COO
CMRCCommerce.com, Inc.
Tax withholding
F$40K
13.5K sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

9
SM
Schwabish MarcChief Business Officer
TECXTectonic Therapeutic, Inc.
Grant or award
A—
17.8K sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC Form 4

Evidence

9
AD
Anderson Woodrow DChief Accounting Officer
INDVIndivior Pharmaceuticals, Inc.
Option exercise
M—
5,946 sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

9
VR
Vakacherla RaviCDIO of Provident Bank
PFSPROVIDENT FINANCIAL SERVICES INC
Tax withholding
F$13K
590 sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC Form 4

Evidence

9
PB
PAEPER HOLLY BethDirector
LFUSLITTELFUSE INC /DE
Grant or award
A—
72 sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC Form 4

Evidence

9
TM
Trzcinski Leah MarieChief Legal Officer
DFINDonnelley Financial Solutions, Inc.
Grant or award
A—
600 sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

9
GR
Gonzalez Lissette REVP, Chief Commercial Officer
BLMNBloomin' Brands, Inc.
Option exercise
M—
4,861 sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence